Arrakis Bio vs CRISPR Therapeutics
Arrakis Bio vs CRISPR Therapeutics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Arrakis Bio is on 48/100 and CRISPR Therapeutics on 64/100.
Where each one leads
Arrakis Bio
Leads on none of the measures we hold for both companies.
CRISPR Therapeutics
- our overall score: 64/100 against 48/100
- domain rating: 67/100 against 2/100
At a glance
| Measure | Arrakis Bio | CRISPR Therapeutics |
|---|---|---|
| What it is | Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform. | Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology. |
| Category | Life Sciences, Agritech, Food, Biotech | Biotechnology, Gene Editing, Therapeutics, Pharmaceuticals |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2019 | 2013 |
| Headquarters | Cambridge, United States | Zug, Switzerland |
| Status | Active | Active |
Size, funding and growth
| Measure | Arrakis Bio | CRISPR Therapeutics |
|---|---|---|
| Employees | 5 | Not published |
| Total funding | Not published | $547M |
| Latest round | Not published | Series B |
| LinkedIn followers | 850 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Arrakis Bio | CRISPR Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 48/100 | 64/100 |
| Traction | 8/100 | 40/100 |
| Team | 30/100 | 70/100 |
| Search visibility | 34/100 | 13/100 |
| Quality | 68/100 | 88/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (43/100) | D (44/100) |
| Domain ratingLink authority, 0-100 | 2/100 | 67/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Arrakis Bio | CRISPR Therapeutics |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CMS | Wix | Not detected |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4 |
| Open source | Yes | No |
Arrakis Bio vs CRISPR Therapeutics: common questions
Which is better, Arrakis Bio or CRISPR Therapeutics?
On our 0-100 score CRISPR Therapeutics rates higher (64/100 against 48/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Arrakis Bio and CRISPR Therapeutics compare on the numbers?
CRISPR Therapeutics leads on our overall score (64/100 against 48/100), domain rating (67/100 against 2/100).
Read the full Arrakis Bio review and pricing or the CRISPR Therapeutics review and pricing. You can also browse other Arrakis Bio alternatives we track.